| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |